In recent years, the landscape of pharmaceutical research and development has undergone a significant transformation, with biologics steadily overtaking small molecule drugs in prominence. This shift has brought forth a new era in clinical trials, where the complexity of biologics necessitates a more comprehensive approach to data analysis. Multiomics, the integration of various omics technologies […]
